养心氏片治疗冠心病临床应用中国专家共识

2020-01-02 世界中医药学会联合会消化病专业委员会 中国中西医结合杂志.2020-1.

由世界中医药学会联合会心血管病专业委员会、介入心脏病专业委员会、心脏康复专业委员会、以及中华中医药学会心血管病分会、中国中西医结合学会心血管病专业委员会、中国中医药研究促进会心血管专业委员会共同发起,组织国内中医、西医及中西医结合心血管病专家,遵循“中医和中西医结合临床指南制定”要求,对养心氏片组方基础,药理作用、临床研究、安全性数据,进行系统回顾与总结,讨论并起草了《 养心氏片治疗冠心病临床应用

中文标题:

养心氏片治疗冠心病临床应用中国专家共识

发布日期:

2020-01-02

简要介绍:

由世界中医药学会联合会心血管病专业委员会、介入心脏病专业委员会、心脏康复专业委员会、以及中华中医药学会心血管病分会、中国中西医结合学会心血管病专业委员会、中国中医药研究促进会心血管专业委员会共同发起,组织国内中医、西医及中西医结合心血管病专家,遵循“中医和中西医结合临床指南制定”要求,对养心氏片组方基础,药理作用、临床研究、安全性数据,进行系统回顾与总结,讨论并起草了《 养心氏片治疗冠心病临床应用中国专家共识》。旨在服务临床医师,为养心氏片临床应用提供参考。随着临床实践的深入,新的证据不断发现& 本共识将不断更新和完善。

 

拓展指南:冠心病相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=养心氏片治疗冠心病临床应用中国专家共识)] GetToolGuiderByIdResponse(projectId=1, id=8d1271c00185a379, title=养心氏片治疗冠心病临床应用中国专家共识, enTitle=, guiderFrom=中国中西医结合杂志.2020-1., authorId=null, author=, summary=由世界中医药学会联合会心血管病专业委员会、介入心脏病专业委员会、心脏康复专业委员会、以及中华中医药学会心血管病分会、中国中西医结合学会心血管病专业委员会、中国中医药研究促进会心血管专业委员会共同发起,组织国内中医、西医及中西医结合心血管病专家,遵循“中医和中西医结合临床指南制定”要求,对养心氏片组方基础,药理作用、临床研究、安全性数据,进行系统回顾与总结,讨论并起草了《 养心氏片治疗冠心病临床应用, cover=, journalId=null, articlesId=null, associationId=1865, associationName=世界中医药学会联合会消化病专业委员会, associationIntro=, copyright=0, guiderPublishedTime=Thu Jan 02 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<P>由世界中医药学会联合会心血管病专业委员会、介入心脏病专业委员会、心脏康复专业委员会、以及中华中医药学会心血管病分会、中国中西医结合学会心血管病专业委员会、中国中医药研究促进会心血管专业委员会共同发起,组织国内中医、西医及中西医结合心血管病专家,遵循“中医和中西医结合临床指南制定”要求,对养心氏片组方基础,药理作用、临床研究、安全性数据,进行系统回顾与总结,讨论并起草了《 养心氏片治疗冠心病临床应用中国专家共识》。旨在服务临床医师,为养心氏片临床应用提供参考。随着临床实践的深入,新的证据不断发现& 本共识将不断更新和完善。 </P> <P> </P>拓展指南:<strong>与<font color=red>冠心病</font>相关指南:</strong><br><ul><li><a href="https://www.medsci.cn/guideline/show_article.do?id=b6f001c0018a29bf" title="速效救心丸治疗冠心病中国专家共识" target=_blank>速效救心丸治疗冠心病中国专家共识</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=accc91c0018263f1" title="冠心病稳定型心绞痛中医诊疗指南" target=_blank>冠心病稳定型心绞痛中医诊疗指南</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=b2ea41c001813e5c" title="中药、天然药物治疗冠心病心绞痛临床研究技术指导原则" target=_blank>中药、天然药物治疗冠心病心绞痛临床研究技术指导原则</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=a89e81c0018023cf" title="物理技术治疗冠心病的实践指南" target=_blank>物理技术治疗冠心病的实践指南</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=971171c001e15ad0" title="稳定性冠心病中西医结合康复治疗专家共识" target=_blank>稳定性冠心病中西医结合康复治疗专家共识</a></li> 更多信息请点击:<a href="https://www.medsci.cn/guideline/list.do?q=%E5%86%A0%E5%BF%83%E7%97%85" target=_blank>有关冠心病更多指南</a></ul>, tagList=[TagDto(tagId=99040, tagName=养心氏片), TagDto(tagId=703, tagName=冠心病), TagDto(tagId=611, tagName=临床应用)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=43, categoryName=冠心病, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=4021, appHits=126, showAppHits=20, pcHits=1655, showPcHits=2966, likes=54, shares=5, comments=4, approvalStatus=1, publishedTime=Sat Jan 25 21:35:11 CST 2020, publishedTimeString=2020-01-02, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Sat Jan 25 21:35:11 CST 2020, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 20:26:01 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=养心氏片治疗冠心病临床应用中国专家共识)])
养心氏片治疗冠心病临床应用中国专家共识
下载请点击:
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=998067, encodeId=ba9399806ea1, content=实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJviaibichlicAGyrZNia2Fzj49EPh7z61kYMbU1Y4sb6q9TR3a1265MCkaAqn2JtiaIMUsW02qe0ZjRl3w/132, createdBy=2c6f5311918, createdName=xsf, createdTime=Fri Jul 09 20:47:08 CST 2021, time=2021-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=912599, encodeId=00eb912599ec, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef2c1960942, createdName=1e1366a1m07(暂无匿称), createdTime=Thu Dec 31 16:05:46 CST 2020, time=2020-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892262, encodeId=ccff892262c4, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97d65426249, createdName=ms3000001511601570, createdTime=Thu Oct 15 16:31:23 CST 2020, time=2020-10-15, status=1, ipAttribution=)]
    2021-07-09 xsf

    实用

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=998067, encodeId=ba9399806ea1, content=实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJviaibichlicAGyrZNia2Fzj49EPh7z61kYMbU1Y4sb6q9TR3a1265MCkaAqn2JtiaIMUsW02qe0ZjRl3w/132, createdBy=2c6f5311918, createdName=xsf, createdTime=Fri Jul 09 20:47:08 CST 2021, time=2021-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=912599, encodeId=00eb912599ec, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef2c1960942, createdName=1e1366a1m07(暂无匿称), createdTime=Thu Dec 31 16:05:46 CST 2020, time=2020-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892262, encodeId=ccff892262c4, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97d65426249, createdName=ms3000001511601570, createdTime=Thu Oct 15 16:31:23 CST 2020, time=2020-10-15, status=1, ipAttribution=)]
    2020-12-31 1e1366a1m07(暂无匿称)

    不错

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=998067, encodeId=ba9399806ea1, content=实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJviaibichlicAGyrZNia2Fzj49EPh7z61kYMbU1Y4sb6q9TR3a1265MCkaAqn2JtiaIMUsW02qe0ZjRl3w/132, createdBy=2c6f5311918, createdName=xsf, createdTime=Fri Jul 09 20:47:08 CST 2021, time=2021-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=912599, encodeId=00eb912599ec, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef2c1960942, createdName=1e1366a1m07(暂无匿称), createdTime=Thu Dec 31 16:05:46 CST 2020, time=2020-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892262, encodeId=ccff892262c4, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97d65426249, createdName=ms3000001511601570, createdTime=Thu Oct 15 16:31:23 CST 2020, time=2020-10-15, status=1, ipAttribution=)]
    2020-10-15 ms3000001511601570

    不错

    0